Demand for neural autoantibody testing continues to grow year over year, as has the number of neural autoantibodies described. Interest in this testing is fueled by increasing recognition that patients with neural autoantibodies may have immunotherapy-responsive forms of psychosis, epilepsy, and rapidly progressive dementia, among others. This rapid growth has come with significant challenges for both the clinical laboratory and the patient-facing physician. At the end of this talk, attendees will recognize key features of autoimmune neurologic disorders, be able to describe different testing methods and how these impact interpretation of laboratory results, discuss challenges associated with appropriate test ordering, and identify opportunities in their own laboratory to improve neural autoantibody test utilization.Faculty/Authors
John Mills, PhDLisa Peterson, PhDPhysician Competencies: Patient Care, Medical Knowledge, Professionalism, Interpersonal Skills Communication
CME/CMLE Credit: 1.0 Estimated Completion Time: 1 hour Format: Online Educational Activity Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions
To claim CME/CMLE credit for the exercise, do the following:
Faculty Disclosure
Technical Considerations
Release Date: 09/04/2024Review Date:Expiration Date: 03/06/2025